A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis

Megan Coylewright1, Michael J Mack2, David R Holmes3

  • 1Section of Cardiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

Insights

The Heart Team approach improves care for severe aortic stenosis patients but needs clearer definitions and metrics. Optimizing this multidisciplinary model is key for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • The Heart Team approach is a central concept in managing severe aortic stenosis, with Class I recommendations from major societies.
  • It is a requirement for reimbursement for transcatheter aortic valve replacement (TAVR) in the United States.
  • The rationale is to improve patient selection, procedural planning, and management for high-risk patients, ultimately enhancing outcomes.

Purpose of the Study:

  • To define the Heart Team concept in severe aortic stenosis care.
  • To review existing data supporting the effectiveness of the Heart Team approach.
  • To highlight the need for clear definitions and shared metrics for optimal Heart Team implementation.

Main Methods:

  • Literature review of Heart Team applications in severe aortic stenosis.
  • Analysis of current professional society guidelines and reimbursement policies.
  • Comparison with multidisciplinary team models in other specialties like oncology.

Main Results:

  • While the Heart Team approach is widely adopted and recommended, a clear definition and robust supporting data are currently lacking.
  • The multidisciplinary team model has precedent in other medical fields, such as oncology.
  • There is a need for standardized definitions and outcome metrics.

Conclusions:

  • The Heart Team approach is integral to modern severe aortic stenosis management.
  • Further research is needed to establish clear definitions and evidence-based metrics for Heart Team effectiveness.
  • Focusing on patient, clinician, and health system outcomes will advance understanding and optimization of this approach.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
413
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
483
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
393
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
602
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
571